Abstract
Lung metastases are commonly seen in many cancers as a result of rich blood circulation. As the concept of oligometastases arouses interest local ablative therapies of lung metastases is being applied more commonly in clinical practice. Pulmonary metastasectomy and stereotactic ablative radiation therapy are the most common forms of local ablative therapies of second lung cancers. Here we present the current evidence about the treatment of second lung cancers including metastases and second primaries.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agolli L, Valeriani M, Nicosia L et al (2015) Stereotactic ablative body radiotherapy (SABR) in pulmonary oligometastatic/oligorecurrent non-small cell lung cancer patients: a new therapeutic approach. Anticancer Res 35(11):6239–6245
Ahmed KA, Scott JG, Arrington JA et al (2018) Radiosensitivity of lung metastases by primary histology and implications for stereotactic body radiation therapy using the genomically adjusted radiation dose. J Thorac Oncol. https://doi.org/10.1016/j.jtho.2018.04.027
Al-Hallaq HA, Chmura SJ, Salama JK et al (2017) Benchmark credentialing results for NRG-BR001: the First National Cancer Institute-sponsored trial of stereotactic body radiation therapy for multiple metastases. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2016.09.030
Ayoub Z, Ning MS, Brooks ED et al (2020) Definitive management of presumed synchronous early stage non-small cell lung cancers: outcomes and utility of stereotactic ablative radiation therapy. Int J Radiat Oncol Biol Phys 107(2):261–269. https://doi.org/10.1016/j.ijrobp.2020.02.001. Epub 2020 Feb 7
Baumann BC, Bernstein KDA, DeLaney TF et al (2020) Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: high rates of local control with favorable toxicity. J Surg Oncol 122:877–883. https://doi.org/10.1002/jso.26078
Billingsley KG, Burt ME, Jara E et al (1999) Pulmonary metastases from soft tissue sarcoma: analysis of patterns of disease and postmetastasis survival. Ann Surg 229:602–612. https://doi.org/10.1097/00000658-199905000-00002
Boijsen E, Zsigmond M (1965) Selective angiography of bronchial and intercostal arteries. Acta Radiol Diagn (Stockh) 3:513–528. https://doi.org/10.1177/028418516500300606
Borm KJ, Oechsner M, Schiller K et al (2018) Prognostic factors in stereotactic body radiotherapy of lung metastases. Strahlenther Onkol 194:886–893. https://doi.org/10.1007/s00066-018-1335-x
Canter RJ, Qin LX, Downey RJ et al (2007) Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity: a retrospective analysis. Cancer 110:2050–2060. https://doi.org/10.1002/cncr.23023
Chen F, Fujinaga T, Shoji T et al (2008) Pulmonary resection for metastasis from renal cell carcinoma. Interact Cardiovasc Thorac Surg 7:825–828. https://doi.org/10.1510/icvts.2008.181065
De Pas TM, de Braud F, Catalano G et al (2007) Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era. Ann Thorac Surg 83:231–234. https://doi.org/10.1016/j.athoracsur.2006.08.017
De Rose F, Cozzi L, Navarria P et al (2016) Clinical outcome of stereotactic ablative body radiotherapy for lung metastatic lesions in non-small cell lung cancer oligometastatic patients. Clin Oncol 28:13–20. https://doi.org/10.1016/j.clon.2015.08.011
Duda DG, Duyverman AMMJ, Kohno M et al (2010) Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci U S A 107:21677–21682. https://doi.org/10.1073/pnas.1016234107
Ferguson MK (1993) Synchronous primary lung cancers. Chest 103(4 Suppl):398S–400S. https://doi.org/10.1378/chest.103.4_supplement.398s
Filippi AR, Guerrera F, Badellino S et al (2016) Exploratory analysis on overall survival after either surgery or stereotactic radiotherapy for lung oligometastases from colorectal cancer. Clin Oncol 28:505–512. https://doi.org/10.1016/j.clon.2016.02.001
Franceschini D, Cozzi L, De Rose F et al (2017) Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours. J Cancer Res Clin Oncol 143:1293–1299. https://doi.org/10.1007/s00432-017-2373-y
Gadd MA, Casper ES, Woodruff JM et al (1993) Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg. https://doi.org/10.1097/00000658-199312000-00002
Gerull WD, Puri V, Kozower BD (2020) The epidemiology and biology of pulmonary metastases. J Thorac Dis 13(4):2585–2589. https://doi.org/10.21037/jtd.2020.04.28
Gloeckler Ries LA, Reichman ME, Lewis DR et al (2003) Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 8:541–552. https://doi.org/10.1634/theoncologist.8-6-541
Gomez DR, Tang C, Zhang J et al (2019) Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol 37:1558–1565. https://doi.org/10.1200/JCO.19.00201
Guckenberger M, Lievens Y, Bouma AB et al (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21:e18–e28. https://doi.org/10.1016/S1470-2045(19)30718-1
Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8–10
Higashiyama M, Kodama K, Higaki N et al (2003) Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis. Jpn J Thorac Cardiovasc Surg 51:289–296. https://doi.org/10.1007/BF02719380
Hiratsuka S, Watanabe A, Aburatani H, Maru Y (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8:1369–1375. https://doi.org/10.1038/ncb1507
Hof H, Hoess A, Oetzel D et al (2007) Stereotactic single-dose radiotherapy of lung metastases. Strahlenther Onkol 183:673–678. https://doi.org/10.1007/s00066-007-1724-z
Hörner-Rieber J, Bernhardt D, Blanck O et al (2019) Long-term follow-up and patterns of recurrence of patients with oligometastatic NSCLC treated with pulmonary SBRT. Clin Lung Cancer 20:e667–e677. https://doi.org/10.1016/j.cllc.2019.06.024
Iizasa T, Suzuki M, Yoshida S et al (2006) Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg 82:254–260. https://doi.org/10.1016/j.athoracsur.2006.02.027
Isaiah JF, Margaret LK (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science 197:893–895
Iyengar P, Wardak Z, Gerber DE et al (2018) Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol 4(1):e173501
Jeremic B, Shibamoto Y, Acimovic L et al (2001) Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone. J Clin Oncol 19(4):1056–1063. https://doi.org/10.1200/JCO.2001.19.4.1056
Jingu K, Matsushita H, Yamamoto T et al (2018) Stereotactic radiotherapy for pulmonary oligometastases from colorectal cancer: a systematic review and meta-analysis. Technol Cancer Res Treat 17:1–7. https://doi.org/10.1177/1533033818794936
Kaifi JT, Gusani NJ, Deshaies I et al (2010) Indications and approach to surgical resection of lung metastases. J Surg Oncol 102:187–195. https://doi.org/10.1002/jso.21596
Kalinauskaite GG, Tinhofer II, Kufeld MM et al (2020) Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases. BMC Cancer 20:1–10. https://doi.org/10.1186/s12885-020-06892-4
Kanzaki R, Higashiyama M, Fujiwara A et al (2011) Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience. Eur J Cardiothorac Surg 39:167–172. https://doi.org/10.1016/j.ejcts.2010.05.021
Kanzaki R, Suzuki O, Kanou T et al (2020) The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors. J Cardiothorac Surg 15:1–7. https://doi.org/10.1186/s13019-020-1079-4
Kaplan RN, Riba RD, Zacharoulis S et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820–827. https://doi.org/10.1038/nature04186
Karam JA, Rini BI, Varella L et al (2011) Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol. https://doi.org/10.1016/j.juro.2010.09.086
Kim SY, Lee CH, Midura BV et al (2008) Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 25:201–211. https://doi.org/10.1007/s10585-007-9133-3
Klement RJ (2017) Radiobiological parameters of liver and lung metastases derived from tumor control data of 3719 metastases. Radiother Oncol. https://doi.org/10.1016/j.radonc.2017.03.014
Kliche S, Waltenberger J (2001) VEGF receptor signaling and endothelial function. IUBMB Life 52:61–66. https://doi.org/10.1080/15216540252774784
Koga R, Yamamoto J, Saiura A et al (2006) Surgical resection of pulmonary metastases from colorectal cancer: four favourable prognostic factors. Jpn J Clin Oncol 36:643–648. https://doi.org/10.1093/jjco/hyl076
Kondo H, Okumura T, Ohde Y, Nakagawa K (2005) Surgical treatment for metastatic malignancies. Pulmonary metastasis: indications and outcomes. Int J Clin Oncol 10:81–85. https://doi.org/10.1007/s10147-004-0472-7
König L, Häfner MF, Katayama S et al (2020) Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients. Radiat Oncol 15:1–9. https://doi.org/10.1186/s13014-020-1480-0
Lee YH, Kang KM, Choi HS et al (2018) Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases. Thorac Cancer 9:1671–1679. https://doi.org/10.1111/1759-7714.12880
Lodeweges JE, Klinkenberg TJ, Ubbels JF et al (2017) Long-term outcome of surgery or stereotactic radiotherapy for lung oligometastases. J Thorac Oncol 12:1442–1445. https://doi.org/10.1016/j.jtho.2017.05.015
Mehta N, Selch M, Wang PC et al (2013) Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma. Sarcoma. https://doi.org/10.1155/2013/360214
Meimarakis G, Angele M, Staehler M et al (2011) Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases. Am J Surg 202:158–167. https://doi.org/10.1016/j.amjsurg.2010.06.029
Milne ENC, Zerhouni EA (1987) Blood supply of pulmonary metastases. J Thorac Imaging. https://doi.org/10.1097/00005382-198710000-00005
Murakami T, Maki W, Cardones AR et al (2002) Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62:7328–7334
Navarria P, Ascolese AM, Cozzi L et al (2015) Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. Eur J Cancer 51:668–674. https://doi.org/10.1016/j.ejca.2015.01.061
Neuman HB, Patel A, Hanlon C et al (2007) Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol 14:2847–2853. https://doi.org/10.1245/s10434-007-9448-y
Niibe Y, Yamashita H, Sekiguchi K et al (2015) Stereotactic body radiotherapy results for pulmonary oligometastases: a two-institution collaborative investigation. Anticancer Res 35:4903–4908
Nikitas J, DeWees T, Rehman S et al (2019) Stereotactic body radiotherapy for early-stage multiple primary lung cancers. Clin Lung Cancer 20(2):107–116. https://doi.org/10.1016/j.cllc.2018.10.010. Epub 2018 Nov 3
Noonan CD, Margulis AR, Wright R (1965) Bronchial arterial patterns in pulmonary metastasis. Radiology 84:1033–1042. https://doi.org/10.1148/84.6.1033
Norihisa Y, Nagata Y, Takayama K et al (2008) Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2008.01.002
Nuyttens JJ, Der Voort V, Van Zyp NCMG, Verhoef C et al (2015) Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study. Int J Radiat Oncol Biol Phys 91:337–343. https://doi.org/10.1016/j.ijrobp.2014.10.021
Oh D, Ahn YC, Seo JM et al (2012) Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung. Acta Oncol (Madr) 51:596–602. https://doi.org/10.3109/0284186X.2012.681698
Okunieff P, Petersen AL, Philip A et al (2006) Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol (Madr) 45:808–817. https://doi.org/10.1080/02841860600908954
Onimaru R, Shirato H, Shimizu S et al (2003) Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56:126–135. https://doi.org/10.1016/S0360-3016(03)00095-6
Osti MF, Carnevale A, Valeriani M et al (2013) Clinical outcomes of single dose stereotactic radiotherapy for lung metastases. Clin Lung Cancer. https://doi.org/10.1016/j.cllc.2013.06.006
Palma DA, Salama JK, Lo SS et al (2014) The oligometastatic state-separating truth from wishful thinking. Nat Rev Clin Oncol 11:549–557. https://doi.org/10.1038/nrclinonc.2014.96
Palma DA, Olson R, Harrow S et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393:2051–2058. https://doi.org/10.1016/S0140-6736(18)32487-5
Pasalic D, Lu Y, Betancourt-Cuellar SL et al (2020) Stereotactic ablative radiation therapy for pulmonary metastases: improving overall survival and identifying subgroups at high risk of local failure. Radiother Oncol 145:178–185. https://doi.org/10.1016/j.radonc.2020.01.010
Pastorino U, Buyse M, Friedel G et al (1997) Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 113:37–49. https://doi.org/10.1016/S0022-5223(97)70397-0
Petersen RP, Hanish SI, Haney JC et al (2007) Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 133:104–110. https://doi.org/10.1016/j.jtcvs.2006.08.065
Pfannschmidt J, Muley T, Hoffmann H, Dienemann H (2003) Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg 126:732–739. https://doi.org/10.1016/S0022-5223(03)00587-7
Pfannschmidt J, Dienemann H, Hoffmann H (2007) Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 84:324–338. https://doi.org/10.1016/j.athoracsur.2007.02.093
Reyes DK, Pienta KJ (2015) The biology and treatment of oligometastatic cancer. Oncotarget 6:8491–8524. https://doi.org/10.18632/oncotarget.3455
Ricardi U, Filippi AR, Guarneri A et al (2012) Stereotactic body radiation therapy for lung metastases. Lung Cancer. https://doi.org/10.1016/j.lungcan.2011.04.021
Ricco A, Davis J, Rate W et al (2017) Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience. Radiat Oncol 12:4–11. https://doi.org/10.1186/s13014-017-0773-4
Rieber J, Streblow J, Uhlmann L et al (2016) Lung cancer stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—a pooled analysis of the German working group “stereotactic radiotherapy”. Lung Cancer 97:51–58. https://doi.org/10.1016/j.lungcan.2016.04.012
Rosengart TK, Martini N, Ghosn P et al (1991) Multiple primary lung carcinomas: prognosis and treatment. Ann Thorac Surg 52(4):773–778. https://doi.org/10.1016/0003-4975(91)91209-e
Rusthoven KE, Kavanagh BD, Burri SH et al (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 27:1579–1584. https://doi.org/10.1200/jco.2008.19.6386
Schueller G, Herold CJ (2003) Lung metastases. Cancer Imaging 3:126–128. https://doi.org/10.1102/1470-7330.2003.0010
Soyfer V, Corn BW, Kollender Y et al (2010) Radiation therapy for palliation of sarcoma metastases: a unique and uniform hypofractionation experience. Sarcoma. https://doi.org/10.1155/2010/927972
Steber CR, Hughes RT, Soike MH et al (2021) Stereotactic body radiotherapy for synchronous early stage non-small cell lung cancer. Acta Oncol. https://doi.org/10.1080/0284186X.2021.1892182
Stragliotto CL, Karlsson K, Lax I et al (2012) A retrospective study of SBRT of metastases in patients with primary sarcoma. Med Oncol 29:3431–3439. https://doi.org/10.1007/s12032-012-0256-2
Swetter SM, Tsao H, Bichakjian CK et al (2019) Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 80:208–250. https://doi.org/10.1016/j.jaad.2018.08.055
Timmerman R, Papiez L, McGarry R et al (2003) Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124:1946–1955. https://doi.org/10.1378/chest.124.5.1946
Treasure T, Miloševíc M, Fiorentino F, Macbeth F (2014) Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness? Thorax 69:946–949. https://doi.org/10.1136/thoraxjnl-2013-204528
Van Geel AN, Pastorino U, Jauch KW et al (1996) Surgical treatment of lung metastases: the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer. https://doi.org/10.1002/(SICI)1097-0142(19960215)77:4<675::AID-CNCR13>3.0.CO;2-Y
Verstegen NE, Oosterhuis JWA, Palma DA et al (2013) Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 24:1543–1548. https://doi.org/10.1093/annonc/mdt026
Videtic GMM, Donington J, Giuliani M et al (2017) Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline. Pract Radiat Oncol 7(5):295–301. https://doi.org/10.1016/j.prro.2017.04.014. Epub 2017 Jun 5
Wang JM, Deng X, Gong W, Su S (1998) Chemokines and their role in tumor growth and metastasis. J Immunol Methods 220:1–17. https://doi.org/10.1016/S0022-1759(98)00128-8
Weigelt B, Glas AM, Wessels LFA et al (2003) Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci U S A 100:15901–15905. https://doi.org/10.1073/pnas.2634067100
Weigelt B, Wessels LFA, Bosma AJ et al (2005) No common denominator for breast cancer lymph node metastasis. Br J Cancer 93:924–932. https://doi.org/10.1038/sj.bjc.6602794
Welter S, Jacobs J, Krbek T et al (2007) Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg 31:167–172. https://doi.org/10.1016/j.ejcts.2006.11.004
Widder J, Klinkenberg TJ, Ubbels JF et al (2013) Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? Radiother Oncol 107:409–413. https://doi.org/10.1016/j.radonc.2013.05.024
Xu L, Burke AP (2012) Pulmonary oligometastases: histological features and difficulties in determining site of origin. Int J Surg Pathol 20:577–588. https://doi.org/10.1177/1066896912449039
Yamamoto T, Niibe Y, Matsumoto Y et al (2020) Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma. J Radiat Res 61:935–944. https://doi.org/10.1093/jrr/rraa071
Yancopoulos GD, Davis S, Gale NW et al (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242–248. https://doi.org/10.1038/35025215
Yu W, Liu Z, Tang L et al (2017) Efficacy and safety of stereotactic radiosurgery for pulmonary metastases from osteosarcoma: experience in 73 patients. Sci Rep 7:1–9. https://doi.org/10.1038/s41598-017-14521-7
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rzazade, R., Caglar, H.B. (2022). Treatment of Second Lung Cancers. In: Jeremić, B. (eds) Advances in Radiation Oncology in Lung Cancer. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2022_329
Download citation
DOI: https://doi.org/10.1007/174_2022_329
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-34846-4
Online ISBN: 978-3-031-34847-1
eBook Packages: MedicineMedicine (R0)